| STS-135 |
| 1-(5-Fluoropentyl)-N-tricyclo[3.3.1.1(3,7)]dec-1-yl-1H-indole-3-carboxamide |
| (CAS 1354631-26-7) |
 |
| Description： |
STS-135 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide) is a designer drug offered by online vendors as a cannabimimetic agent. The structure of STS-135 appears to utilise an understanding of structure-activity relationships within the indole class of cannabimimetics, although its design origins are unclear. STS-135 is the terminally-fluorinated analogue of SDB-001, just as AM-2201 is the terminally-fluorinated analogue of JWH-018, and XLR-11 is the terminally-fluorinated analogue of UR-144. No information regarding the in vitro or in vivo activity of STS-135 has been published, and only anecdotal reports are known of its pharmacology in humans or other animals.
|
| Product No. |
KT00858 |
| Product Name |
STS-135 |
| Synonyms |
N-adamantyl-1-fluoropentylindole-3-Carboxamide |
| Formal Name |
1-(5-Fluoropentyl)-N-tricyclo[3.3.1.1(3,7)]dec-1-yl-1H-indole-3-carboxamide |
| CAS Number |
1354631-26-7 |
| Molecular Formula |
C24H31FN2O |
| Formula Weight |
382.51 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
|
